Armaya Fuerte 120 Mg 24 Capsules
Treatment of symptoms associated with mild to moderate inflammatory processes of the skin.
Treatment of symptoms associated with mild to moderate inflammatory processes of the skin.
Armaya Fuerte (120 Mg 24 Capsules)
INDICATIONS
- [DERMATITIS]. Treatment of symptoms associated with mild to moderate inflammatory processes of the skin.
Its use is based exclusively on a traditional use
POSOLOGY
- Adults and adolescents over 12 years, oral: 1 capsule 3 times a day. If necessary, an additional capsule may be administered preferably at night. The treatment will last up to 4 weeks, unless medical recommendation.
- Children 6-12 years: 1 capsule / 12 h.
- Children <6 years: safety and efficacy have not been evaluated.
Take 30 min before the main meals.
If symptoms continue or worsen after 2 weeks of treatment it is recommended to consult with the doctor and / or pharmacist.
RULES FOR THE CORRECT ADMINISTRATION
Take the capsules whole with the help of some liquid.
CONTRAINDICATIONS
- Hypersensitivity to any component of the medication.
PRECAUTIONS
- Patients with [FEVER], [INFECTION], [ARTERIAL HYPERTENSION] or [HEART INSUFFICIENCY] should use this medication upon medical recommendation.
PRECAUTIONS RELATING TO EXCIPIENTS
- This medicine contains lactose. Patients with hereditary or galactose [INTOLERANCE TO LACTOSE], Lapp lactase insufficiency or glucose or galactose malabsorption should not take this medicine.
- This medicine contains lactose. The intake of amounts greater than 5 g daily should be taken into account in patients with [DIABETES] and with intolerance to certain sugars.
PATIENT ADVICE
- Take 30 min before meals.
- The treatment will continue for a maximum of 4 weeks, unless the doctor indicates otherwise.
- If the symptoms continue or worsen after 2 weeks of treatment it is recommended to consult with the doctor and / or pharmacist.
- Avoid drinking alcoholic beverages during treatment.
INTERACTIONS
- Alcohol. Alcoholic beverages may alter the absorption of Polypodium leucotomos extract. It is recommended to avoid alcohol consumption during treatment.
- Antacids. It is recommended to avoid the use of antacids immediately before administration, as digestive absorption could be reduced.
PREGNANCY
Animal safety : no data available.
Safety in humans : adequate and well-controlled studies in humans are not available. It is recommended to avoid its use during pregnancy.
Fertility effects : no data are available about its possible effects on fertility.
LACTATION
It is unknown if it is excreted with milk, and the consequences it could have for the infant. Is recomended to suspend the lactancy or evy the administration.
CHILDREN
The safety and efficacy in children under 6 years of age have not been evaluated, so it is recommended to avoid their use. Children between 6 and 12 years old require a dose adjustment.
ELDERLY
No specific problems have been described in the elderly.
EFFECTS ON DRIVING
It does not appear to significantly affect the ability to drive or operate dangerous machinery.
ADVERSE REACTIONS
Adverse reactions are described according to each frequency range, being considered very frequent (> 10%), frequent (1-10%), rare (0.1-1%), rare (0.01-0.1%) , very rare (<0.01%) or of unknown frequency (cannot be estimated from the available data).
- Digestive: rare digestive disorders.
- Dermatological: rare [EXANTEMATIC ERUPTIONS], [PRURITE].
ADVERSE REACTIONS CONCERNING EXCIPIENTS
- This medicine contains lactose, which may have milk proteins. It could cause [HYPERSENSITIVITY REACTIONS] in people with a cow's milk protein allergy.
OVERDOSE
Symptoms: no cases of overdose have been described.
Treatment: symptomatic.